Veracyte, Inc.
VCYT
$32.13
$1.203.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.65% | 1.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.65% | 1.31% | |||
| Cost of Revenue | 30.31% | -7.75% | |||
| Gross Profit | -1.84% | 5.01% | |||
| SG&A Expenses | -14.92% | -6.70% | |||
| Depreciation & Amortization | 0.00% | 1.25% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.68% | -6.12% | |||
| Operating Income | 6.49% | 61.49% | |||
| Income Before Tax | 115.12% | 1,411.12% | |||
| Income Tax Expenses | -107.66% | -111.12% | |||
| Earnings from Continuing Operations | 115.02% | 2,052.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 115.02% | 2,052.76% | |||
| EBIT | 6.49% | 61.49% | |||
| EBITDA | 5.40% | 43.32% | |||
| EPS Basic | 113.78% | 2,044.80% | |||
| Normalized Basic EPS | -17.60% | 23.12% | |||
| EPS Diluted | 107.29% | 2,020.00% | |||
| Normalized Diluted EPS | -18.90% | 21.67% | |||
| Average Basic Shares Outstanding | 0.58% | 0.43% | |||
| Average Diluted Shares Outstanding | 2.13% | 1.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||